These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11460395)

  • 1. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice].
    Faulhaber HD
    MMW Fortschr Med; 2001 May; 143(22):30-2. PubMed ID: 11460395
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J; Solar M
    Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
    Wepner U
    MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
    Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
    Cheng TO
    Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Doxazosin and heart failure: a clinical conclusion is wanted].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 Dec; 100(51-52):4328. PubMed ID: 14756102
    [No Abstract]   [Full Text] [Related]  

  • 7. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].
    Gustafsson LL
    Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxazosin and congestive heart failure.
    Messerli FH
    J Am Coll Cardiol; 2001 Nov; 38(5):1295-6. PubMed ID: 11691497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial.
    Vidt DG
    Cleve Clin J Med; 2000 Jun; 67(6):429-33. PubMed ID: 10860225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a multicenter trial of antihypertensive treatment with atenolol, alone or in combination with chlorthalidone, of patients with mild, moderate and severe hypertension].
    Novo S; Giannola A; Immordino R; Strano A
    Cardiologia; 1987 Jan; 32(1):33-49. PubMed ID: 3555793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of the month. The ALLHAT study: a recommendation for prudence in the use of alpha-blockers for the treatment of hypertension].
    Kulbertus H
    Rev Med Liege; 2000 Jul; 55(7):754-5. PubMed ID: 11014112
    [No Abstract]   [Full Text] [Related]  

  • 12. [The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
    Düsing R
    MMW Fortschr Med; 2003; 145 Suppl 1():6. PubMed ID: 12958795
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxazosin, an inferior antihypertensive agent?
    Furberg CD
    J Hum Hypertens; 2002 Jun; 16(6):375-7. PubMed ID: 12037690
    [No Abstract]   [Full Text] [Related]  

  • 14. Doxazosin gastrointestinal therapeutic system: a clinical perspective.
    Mann SJ
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):207-8. PubMed ID: 16522999
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing].
    Sauerbrey-Wullkopf N; Leverkus F
    MMW Fortschr Med; 2003 Nov; 145(47):54. PubMed ID: 14725035
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxazosin and heart failure: to be or not to be.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    J Hypertens; 2009 Feb; 27(2):433-4; author reply 434-5. PubMed ID: 19155795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K; van der Tuin J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?
    Chapman N; Chen CY; Fujita T; Hobbs FD; Kim SJ; Staessen JA; Tanomsup S; Wang JG; Williams B
    J Hypertens; 2010 Sep; 28(9):1796-803. PubMed ID: 20543713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q: Should alpha-blockers ever be used as antihypertensive drugs?
    Rossitto G; Kamath G; Messerli FH
    Cleve Clin J Med; 2010 Dec; 77(12):884-8. PubMed ID: 21147942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.